MedTrace Logo

Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma

NCT00450593 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2013-08-12

No results posted yet for this study

Summary

RATIONALE: Identifying gene mutations and other risk factors in patients with melanoma and in families with a history of hereditary melanoma may help doctors identify persons at risk for melanoma and other types of cancer. It may also help the study of cancer in the future.

PURPOSE: This clinical trial is studying gene mutations in patients with melanoma and in families with a history of hereditary melanoma.

Conditions

  • Hereditary Multiple Melanoma
  • Melanoma (Skin)

Interventions

GENETIC

gene expression analysis

GENETIC

microarray analysis

GENETIC

molecular genetic technique

GENETIC

mutation analysis

OTHER

laboratory biomarker analysis

PROCEDURE

mutation carrier screening

PROCEDURE

study of high risk factors

Sponsors & Collaborators

  • Leeds Cancer Centre at St. James's University Hospital

    lead OTHER

Principal Investigators

  • Julia Newton Bishop, MD · Leeds Cancer Centre at St. James's University Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1989-01-31
Primary Completion
2020-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00450593 on ClinicalTrials.gov